<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">the </span>
   <span class="font23">and </span>
   <span class="font21">HCV </span>
   <span class="font20">with </span>
   <span class="font18">{background </span>
   <span class="font16">was </span>
   <span class="font16">margin </span>
   <span class="font16">{border-style </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">RNA </span>
   <span class="font15">lesions </span>
   <span class="font14">her </span>
   <span class="font14">were </span>
   <span class="font14">that </span>
   <span class="font13">hepatitis </span>
   <span class="font13">drug </span>
   <span class="font13">for </span>
   <span class="font13">not </span>
   <span class="font13">had </span>
   <span class="font13">levels </span>
   <span class="font13">she </span>
   <span class="font13">skin </span>
   <span class="font12">The </span>
   <span class="font12">amlodipine </span>
   <span class="font12">but </span>
   <span class="font12">patient </span>
   <span class="font12">ribavirin </span>
   <span class="font12">virus </span>
   <span class="font12">FDE </span>
   <span class="font12">immune </span>
   <span class="font12">px; </span>
   <span class="font12">treatment </span>
   <span class="font12">viral </span>
   <span class="font12">{font-family </span>
   <span class="font12">after </span>
   <span class="font12">are </span>
   <span class="font12">clinical </span>
   <span class="font12">erythematous </span>
   <span class="font12">font-size </span>
   <span class="font12">patients </span>
   <span class="font12">responses </span>
   <span class="font12">these </span>
   <span class="font11">IFN </span>
   <span class="font11">can </span>
   <span class="font11">chronic </span>
   <span class="font11">double; </span>
   <span class="font11">fixed </span>
   <span class="font11">infection </span>
   <span class="font11">macules </span>
   <span class="font11">multiple </span>
   <span class="font11">plus </span>
   <span class="font11">reported </span>
   <span class="font11">test </span>
   <span class="font11">which </span>
   <span class="font11">Case </span>
   <span class="font11">She </span>
   <span class="font11">[]. </span>
   <span class="font11">associated </span>
   <span class="font11">been </span>
   <span class="font11">between </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">development </span>
   <span class="font11">drugs </span>
   <span class="font11">eruption </span>
   <span class="font11">from </span>
   <span class="font11">interferon </span>
   <span class="font11">level </span>
   <span class="font11">may </span>
   <span class="font11">results </span>
   <span class="font11">serum </span>
   <span class="font11">several </span>
   <span class="font11">sites </span>
   <span class="font11">solid; </span>
   <span class="font11">this </span>
   <span class="font11">time </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(Fig. </span>
   <span class="font11">Although </span>
   <span class="font11">Dermatol() </span>
   <span class="font11">HCV-specific </span>
   <span class="font11">However, </span>
   <span class="font11">PEG-IFNÎ±-b </span>
   <span class="font11">[], </span>
   <span class="font11">atenolol </span>
   <span class="font11">besilate </span>
   <span class="font11">blood </span>
   <span class="font11">bold </span>
   <span class="font11">candesartan </span>
   <span class="font11">challenge </span>
   <span class="font11">correlation </span>
   <span class="font11">courier; </span>
   <span class="font11">course </span>
   <span class="font11">days </span>
   <span class="font11">during </span>
   <span class="font11">em; </span>
   <span class="font11">eruptions </span>
   <span class="font11">flares </span>
   <span class="font11">history </span>
   <span class="font11">inverse </span>
   <span class="font11">lichen </span>
   <span class="font11">months </span>
   <span class="font11">more </span>
   <span class="font11">parapsoriasis </span>
   <span class="font11">per </span>
   <span class="font11">polysensitivity </span>
   <span class="font11">previously </span>
   <span class="font11">pt;} </span>
   <span class="font11">showed </span>
   <span class="font11">therapy </span>
   <span class="font11">transformation </span>
   <span class="font11">within </span>
  </p>
 </body>
</html>
